Comments on “Development and Validation of a META-Algorithm to Identify the Indications of Use of Biological Drugs Approved for the Treatment of Immune-Mediated Inflammatory Diseases from Claims Databases: Insights from the VALORE Project” [Letter]

Fitri Rokhmalia1 Department of Environmental Health, Poltekkes Kemenkes Surabaya, Surabaya, Indonesia

Dwi Krihariyani2 Department of Medical Laboratory Technology, Poltekkes Kemenkes Surabaya, Surabaya, Indonesia

Sari Luthfiyah3 Department of Nursing, Poltekkes Kemenkes Surabaya, Surabaya, Indonesia

T Triwiyanto4 Department of Medical Electronics Technology, Poltekkes Kemenkes Surabaya, Surabaya, IndonesiaCorrespondence[email protected] [email protected]

References

Spini A, L’Abbate L, Ingrasciotta Y, et al. Development and Validation of a META-Algorithm to Identify the Indications of Use of Biological Drugs Approved for the Treatment of Immune-Mediated Inflammatory Diseases from Claims Databases: insights from the VALORE Project. Clin Epidemiol. 2024;16:395–407. doi:10.2147/CLEP.S445120
PubMed Web of Science ®Google Scholar
Ingrasciotta Y, Spini A, L’Abbate L, et al. Comparing clinical trial population representativeness to real-world users of 17 biologics approved for immune-mediated inflammatory diseases: an external validity analysis of 66,639 biologic users from the Italian VALORE project. Pharmacol Res. 2024;200:107074. doi:10.1016/j.phrs.2024.107074
PubMed Web of Science ®Google Scholar
Monteleone G, Moscardelli A, Colella A, Marafini I, Salvatori S. Immune-mediated inflammatory diseases: common and different pathogenic and clinical features. Autoimmune Rev. 2023;22(10):103410. doi:10.1016/j.autrev.2023.103410
PubMed Web of Science ®Google Scholar
Jourdain H, Hoisnard L, Sbidian E, Zureik M. Persistence and safety of anti-TNF biosimilars versus originators in immune-mediated inflammatory diseases: an observational study on the French National Health Data System. RMD Open. 2024;10(1):e003531. doi:10.1136/rmdopen-2023-003531
PubMed Web of Science ®Google Scholar